The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Prevention and Management of Hereditary Breast Cancer
Abstract
It has been 10 years since the BRCA1 gene was first identified. During this decade, genetic testing for breast cancer susceptibility has been incorporated into the practice of oncology. In this process, the identification of families at the highest hereditary risk for cancer has served as a model to test strategies for prevention or early detection of breast malignancies. An emerging literature has explored primary prevention through risk reducing surgery and chemoprevention, as well as secondary prevention utilizing such approaches as magnetic resonance imaging (MRI) to achieve early detection of breast cancer in women with BRCA1 or BRCA2 mutations. Tailored treatments are being explored for newly diagnosed women with BRCA mutations. Ultimately, individual risk estimates and clinical management plans will be generated for women carrying BRCA mutations, based on consideration of the particular mutation inherited and also on the presence of modifying genetic and environmental factors. Both BRCA1 and BRCA2 are involved in the cellular response to DNA damage and interact with other proteins involved in double-stranded DNA repair. The effects of inherited mutations in these genes are similar, and mutations of both types predispose carriers to female and male breast cancer, and to ovarian cancer. The risk of male breast cancer is higher in BRCA2 carriers; ovarian cancer risk is higher in those carrying BRCA1 mutations. In addition, BRCA2 mutations appear to predispose both men and women to a wide range of other cancer types. The reasons for these tissue-specific differences between the two genes is not clear.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Self-citationUse of proteomic patterns in serum to identify ovarian cancer
Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J., Fusaro, V. A., Steinberg, S. M., Mills, G. B., Simone, C., Fishman, D. A., Kohn, E. C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07746-2 · Cited by 3,236
Rebbeck, T. R., Friebel, T., Lynch, H. T., Neuhausen, S. L., van ’t Veer, L., Garber, J. E., Evans, G. R., Narod, S. A., Isaacs, C., Matloff, E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.188 · Cited by 1,171
Self-citationBreast Cancer after Prophylactic Bilateral Mastectomy in Women with a BRCA1 or BRCA2 Mutation
Meijers-Heijboer, H., van Geel, B., van Putten, W. L. J., Henzen-Logmans, S. C., Seynaeve, C., Menke-Pluymers, M. B. E., Bartels, C. C. M., Verhoog, L. C., van den Ouweland, A. M. W., Niermeijer, M. F., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107193450301 · Cited by 973
BRCA1 and BRCA2: 1994 and beyond
Narod, S. A., & Foulkes, W. D. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1431 · Cited by 967
Self-citationBurke, W. (1997) · JAMA · doi:10.1001/jama.277.12.997 · Cited by 955
Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status
Haffty, B. G., Harrold, E., Khan, A. J., Pathare, P., Smith, T. E., Turner, B. C., Glazer, P. M., Ward, B., Carter, D., Matloff, E., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08434-9 · Cited by 307
Cited by
Manahan, E. R., Kuerer, H. M., Sebastian, M., Hughes, K. S., Boughey, J. C., Euhus, D. M., Boolbol, S. K., & Taylor, W. A. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07549-8 · Cited by 346
Travis, L. B., Rabkin, C. S., Brown, L. M., Allan, J. M., Alter, B. P., Ambrosone, C. B., Begg, C. B., Caporaso, N., Chanock, S., DeMichele, A., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj001 · Cited by 342
Self-citationManagement of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines
Peterson, D. E., Bensadoun, R.-J., & Roila, F. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr391 · Cited by 305
Cragun, D., Weidner, A., Lewis, C., Bonner, D., Kim, J., Vadaparampil, S. T., & Pal, T. (2017) · Cancer · doi:10.1002/cncr.30621 · Cited by 293
Metadata
- Authors
- Narod, S. A., & Offit, K.
- Venue
- Journal of Clinical Oncology
- Published
- 2005-03-10
- Volume
- 23
- Issue
- 8
- Pages
- 1656-1663
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2110439344
- Cited by
- 169
- References
- 7
- FWCI
- 11.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevention and Management of Hereditary Breast Cancer. https://app.cochat.ai/papers/10.1200/jco.2005.10.035
- The paper
- Narod, S. A., & Offit, K. (2005). Prevention and Management of Hereditary Breast Cancer. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2005.10.035
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.